Effect of Neural Mobilization in Bells Palsy: A Randomized Controlled Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 60
Summary
- Conditions
- Bell Palsy
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The study will include minimum of 60 participants visiting the investigator's out-patient department from 2018-2020. The equal allocation procedure will be used based on the admission of the cases.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: The participants, care provider, investigator and outcome assessor will be unaware about the allocation. The therapist performing the initial assessment and the final assessment will be same but will be unaware about the patient assignment.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Bells Palsy responds well with drug therapy such as prednisolone and antiviral drugs for the duration of 10-12 days. However, the administration of these drugs produce adverse side effect. Therapist use a number of techniques to maintain the physiological properties of facial muscles. However, addin...
Bells Palsy responds well with drug therapy such as prednisolone and antiviral drugs for the duration of 10-12 days. However, the administration of these drugs produce adverse side effect. Therapist use a number of techniques to maintain the physiological properties of facial muscles. However, adding a new technique would add to the arsenal of techniques available for the therapist. The research is intended to determine the effect of adding Neural mobilization in the recovery of Bells Palsy. A randomized controlled trail is intended to include 60 participants divided into two groups. Experimental group will receive Neural Mobilization with conservative treatment and control group will receive conservative treatment only.
Tracking Information
- NCT #
- NCT04280120
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon